Our results indicated that the combination of biochanin A and SB590885 suppressed the growth of hepatocellular carcinoma cells via inhibition of the ERK MAPK and PI3K/AKT/mTOR signalling pathways. Here, AKT1 is linked to hepatocellular carcinoma.